Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John D Fisk

Showing results (1-10 of 186) with videos related to

Pageof 19
Sort By:
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|May 2, 2007
Ethical considerations for the conduct of antidementia trials in CanadaJohn D Fisk
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|June 21, 2002
Construction and validation of a fatigue impact scale for daily administration (D-FIS)John D Fisk, Susan E Doble
Nature Reviews. Rheumatology|August 25, 2011
Diagnosis of cognitive impairment in adult and pediatric SLEJohn G Hanly, John D Fisk
Journal of the International Neuropsychological Society : JINS|February 22, 2013
Indices of cognitive dysfunction in relapsing-remitting multiple sclerosis: intra-individual variability, processing speed, and attention network efficiencyMagdalena Wojtowicz, Antonina Omisade, John D Fisk
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|March 2, 2019
Cholinergic Neurons in Nucleus Subputaminalis in Primary Progressive AphasiaHayam Hamodat, John D Fisk, Sultan Darvesh
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 15, 2009
Ethical considerations for decision making for treatment and research participationJohn D Fisk, B Lynn Beattie, Martha Donnelly
Dementia and Geriatric Cognitive Disorders|September 17, 2005
APOE genotype, vascular risk factors, memory test performance and the five-year risk of vascular cognitive impairment or Alzheimer's diseaseJennifer D Klages, John D Fisk, Kenneth Rockwood
The Journal of Rheumatology|August 2, 2006
Anti-NR2 glutamate receptor antibodies and cognitive function in systemic lupus erythematosusJohn G Hanly, Jody Robichaud, John D Fisk
Neurology|November 12, 2003
Variations in case definition affect prevalence but not outcomes of mild cognitive impairmentJohn D Fisk, Heather R Merry, Kenneth Rockwood
Dementia and Geriatric Cognitive Disorders|November 29, 2002
APOE genotype, memory test performance, and the risk of Alzheimer's disease in the Canadian Study of Health and AgingJennifer D Klages, John D Fisk, Kenneth Rockwood
Pageof 19

Showing results (1-10 of 186) with videos related to

Sort By:
Pageof 19
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|May 2, 2007
Ethical considerations for the conduct of antidementia trials in CanadaJohn D Fisk
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|June 21, 2002
Construction and validation of a fatigue impact scale for daily administration (D-FIS)John D Fisk, Susan E Doble
Nature Reviews. Rheumatology|August 25, 2011
Diagnosis of cognitive impairment in adult and pediatric SLEJohn G Hanly, John D Fisk
Journal of the International Neuropsychological Society : JINS|February 22, 2013
Indices of cognitive dysfunction in relapsing-remitting multiple sclerosis: intra-individual variability, processing speed, and attention network efficiencyMagdalena Wojtowicz, Antonina Omisade, John D Fisk
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|March 2, 2019
Cholinergic Neurons in Nucleus Subputaminalis in Primary Progressive AphasiaHayam Hamodat, John D Fisk, Sultan Darvesh
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 15, 2009
Ethical considerations for decision making for treatment and research participationJohn D Fisk, B Lynn Beattie, Martha Donnelly
Dementia and Geriatric Cognitive Disorders|September 17, 2005
APOE genotype, vascular risk factors, memory test performance and the five-year risk of vascular cognitive impairment or Alzheimer's diseaseJennifer D Klages, John D Fisk, Kenneth Rockwood
The Journal of Rheumatology|August 2, 2006
Anti-NR2 glutamate receptor antibodies and cognitive function in systemic lupus erythematosusJohn G Hanly, Jody Robichaud, John D Fisk
Neurology|November 12, 2003
Variations in case definition affect prevalence but not outcomes of mild cognitive impairmentJohn D Fisk, Heather R Merry, Kenneth Rockwood
Dementia and Geriatric Cognitive Disorders|November 29, 2002
APOE genotype, memory test performance, and the risk of Alzheimer's disease in the Canadian Study of Health and AgingJennifer D Klages, John D Fisk, Kenneth Rockwood
Pageof 19